Basal-shift transformation leads to EGFR therapy-resistance in human lung adenocarcinoma
To comprehensively unravel the mechanisms of EGFR-TKI resistance, we establish a biobank of patient-derived EGFR-mutant lung cancer organoids, encompassing cases previously treated with EGFR-TKIs....
Like
Be the first to like this
WORC Update
(He/Him)
Head of community, WORC.Community (A Caterpillar Hill Limited venture).
Thank you for joining us here at WORC! This platform has the sole purpose of bringing Organoid and Organ-on-a-chip researchers together! Easily connect, share content, ideas and experiences in this transformative area of science. The idea for this community came after speaking with many of you expressing the need for joined up thinking and making long lasting connections.
